Clinical Trial
NCT05870566 Recruiting, Active
Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
UV Light-mediated Corneal Crosslinking as (Lymph)Angioregressive Pretreatment to Promote Graft Survival After Subsequent High-risk Corneal Transplantation [CrossCornealVision]
Disease
Disease type
Other
Patient type
Adult
Children
Inclusion / Exclusion
Funding
Public
ERN EYE member investigating site
HCP : Principal investigators
Eye Center, University Hospital Freiburg, Germany
Adress
Killianstraße 5
79106 Freiburg im Breisgau
Germany
Charité – Universitätsmedizin Berlin, Germany
Adress
Charitépl. 1
10117 Berlin
Germany
Klinikum der Universität München, Germany
Adress
Mathildenstraße 8
80336 Munich
Germany